Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and adult toys.
Popular Articles

HESA Performance Indicators Show That 1994 Group Universities Are 'elite But Not Elitist'
1994 Group universities are continuing to widen access to higher education, attracting over 4/5 of their students from state schools for a third consecutive year, as highlighted by statistics published by the Higher Education Statistics Agency (HESA.) As well as increasing their average percentage of entrants from state schools by three times the national average, 1994 Group universities have also achieved drop-out rates well below the sector-wide average for a forth year running, signalling that wider participation and high quality student experience can go hand in hand.
buy viagra
IFPMA R&D Status Report 2009: Industry Research Increasing In Less Well-known Tropical Diseases
The IFPMA has just published the 2009 edition of its Status Report on Pharmaceutical Industry R&D for Diseases of the Developing World(1). This documents research and development projects by IFPMA member companies(2), alone or with partners, to develop medicines and vaccines for the 10 diseases of the developing world (DDW)(3) prioritized by the United Nations" TDR tropical disease research and training organization(4). Member company DDW medicine and vaccine projects have increased from 67 last year to a total of 84 this year. While the number of tuberculosis and malaria projects has grown slightly, projects for the remaining eight tropical diseases have increased markedly from 11 in 2008 to 25 in 2009.
News of the day
Health Canada Confirms No Health Risk From BPA In Baby Food, Powdered Infant Formula, And Bottled Water
As part of its research commitment on bisphenol A (BPA), Health Canada released yesterday the results of studies investigating BPA exposure levels in baby food in glass jars with metal lids, powdered infant formula, and bottled water. The results from these three government studies provide definitive confirmation that baby food products packaged in glass jars with metal lids, powdered infant formula, and bottled water do not pose a health risk. Researchers found that all levels of BPA found in tested products were exceedingly low and all are well below the level established as safe for consumers by the Canadian government. The North American Metal Packaging Alliance, Inc. (NAMPA) welcomes the latest Canadian study, noting that these findings confirm industry"s own research that shows BPA levels in food containers are negligible.
Mental Health

Arizona Heart Institute Enrolls First Patient In Anaconda(TM) Investigational Study For The Treatment Of Abdominal Aortic Aneurysm

Surgeons from Arizona Heart Institute performed the first procedure in the U.S. Anaconda Phase II Study using the Vascutek Anaconda Stent Graft System, an investigational, minimally invasive treatment for abdominal aortic aneurysm (AAA). Leading the study efforts in the U.S. is Julio Rodriguez-Lopez, M.D., Vascular Surgeon, Arizona Heart Institute and Arizona Heart Hospital, and National Principal Investigator. "The Anaconda Stent Graft System has the potential to treat patients with infrarenal AAAs," said Dr. Rodriguez. "In commercial use outside the U.S. Phase II study, this stent graft has been shown to be flexible and repositionable. These are important features when treating patients with infrarenal AAAs," continued Rodriguez. Abdominal aortic aneurysm, or "ballooning" of the body"s main artery, is a serious condition in which the aorta is prone to rupture often causing sudden death. Studies report that emergent, open surgical repair of a ruptured aortic aneurysm carries a 25 to 50 percent risk of death; however, less invasive endovascular procedures involving stent grafts offer a lower-risk alternative to open surgical repair and are associated with minimal blood loss, faster recovery, shorter hospital stays and decreased risk of death. "Experience with the device, which has been used commercially in nearly 4000 patients in Europe, has been very positive," said Donald B. Reid, M.D., Fellow of the Royal College of Surgeons, Consultant Vascular Surgeon, and Chairman of Vascular Surgery with Wishaw General Hospital and University of Glasgow, Scotland, U.K., who attended the procedure at Arizona Heart Hospital. Symptoms of aortic rupture can occur suddenly with severe, sharp pain in the abdomen. Patients who experience these symptoms should seek immediate medical attention. Early detection of aortic aneurysms can prevent sudden death; therefore, patients with a family history of aortic aneurysm or other connective tissue disorders should notify their physician about their risk of aortic aneurysm. About Arizona Heart Institute Arizona Heart Institute (AHI) is among the world"s leading providers of cardiovascular care and world authority in the endovascular treatment of aortic aneurysm and related pathologies. Founded in 1971, AHI has earned its reputation for excellence by creating a state-of-the-art medical facility that specializes in the prevention, diagnosis and treatment of heart and blood vessel disease. In the 1990s, Dr. Edward B. Diethrich, Founder and Medical Director of Arizona Heart Institute and Arizona Heart Hospital, pioneered the development of the very first stent graft for aortic aneurysms. Since then, this minimally invasive technique has become the gold standard worldwide and has changed the way vascular medicine approaches disorders of the aorta. Through dedication, education and innovation, AHI is leading the effort to eliminate cardiovascular disease and discovering new ways to save lives along the way. About the Study The objective of the Vascutek Anaconda Stent Graft System Phase II IDE Study (G030036) is to assess the safety and efficacy of the Anaconda Stent Graft System in patients presenting with AAA, when compared to historical open surgical repair. The study, which is sponsored by Terumo Cardiovascular Systems, Ann Arbor, Michigan, is expected to enroll a total of 180 patients at 20 U.S. sites. The device is manufactured by Vascutek Ltd, a Terumo Company located near Glasgow, Scotland. More information can be found at clinicaltrials.gov NCT00612924. Arizona Heart Institute and Hospital


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009